Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiting Yu

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Nature Immunology|July 22, 2015
Erratum: TET1 is a tumor suppressor of hematopoietic malignancyLuisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, et al.
Nature Medicine|September 8, 2015
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Thomas O Vogler, Swathi Narayanagari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survivalCaroline Y Hu, Davoud Mohtat, Yiting Yu, et al.
The Journal of Biological Chemistry|January 12, 2013
High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesisYiting Yu, Yongkai Mo, David Ebenezer, et al.
Blood|April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.
Blood|February 8, 2013
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signalingTushar D Bhagat, Li Zhou, Lubomir Sokol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesisChristoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromesSriram Sundaravel, Ryan Duggan, Tushar Bhagat, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Cell Reports|December 31, 2013
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesisJozef Madzo, Hui Liu, Alexis Rodriguez, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Nature Immunology|July 22, 2015
Erratum: TET1 is a tumor suppressor of hematopoietic malignancyLuisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, et al.
Nature Medicine|September 8, 2015
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Thomas O Vogler, Swathi Narayanagari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survivalCaroline Y Hu, Davoud Mohtat, Yiting Yu, et al.
The Journal of Biological Chemistry|January 12, 2013
High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesisYiting Yu, Yongkai Mo, David Ebenezer, et al.
Blood|April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.
Blood|February 8, 2013
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signalingTushar D Bhagat, Li Zhou, Lubomir Sokol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesisChristoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromesSriram Sundaravel, Ryan Duggan, Tushar Bhagat, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Cell Reports|December 31, 2013
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesisJozef Madzo, Hui Liu, Alexis Rodriguez, et al.
Pageof 12